Aquestive Therapeutics (AQST) EPS (2018 - 2026)
Aquestive Therapeutics (AQST) EPS from Jun 30, 2018 to Mar 31, 2026. The TTM Aquestive Therapeutics (AQST) EPS is -$0.59. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Aquestive Therapeutics (AQST) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +2.71% |
| 3 Years TTM | -1.65% |
| 5 Years TTM | -17.65% |
| All Time TTM | -19.60% |
Annual EPS change of Aquestive Therapeutics (AQST)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.06 | -90.55% |
| 2025 | -$0.69 | +42.17% |
| 2024 | -$0.48 | +320.48% |
| 2023 | -$0.11 | -88.43% |
| 2022 | -$0.99 | -42.00% |
| 2021 | -$1.71 | +6.03% |
| 2020 | -$1.61 | -18.25% |
| 2019 | -$1.97 | -19.74% |
| 2018 | -$2.46 | N/A |
Comparison Aquestive Therapeutics (AQST) five years EPS CAGR with competitors
Aquestive Therapeutics (AQST) five years EPS CAGR is -17.65%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 101.37% | -674.35% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.58% | -261.94% |
| RGC | Regencell Bioscience Holdings Ltd | 27.66% | -256.71% |
| UTHR | United Therapeutics Corp | 26.56% | -250.48% |
| ANIP | ANI Pharmaceuticals Inc | 25.74% | -245.85% |
| LFCR | Lifecore Biomedical Inc | 16.09% | -191.18% |
| PAHC | Phibro Animal Health Corp - Class A | 15.27% | -186.53% |
| ZTS | Zoetis Inc - Class A | 10.56% | -159.82% |
| NBIX | Neurocrine Biosciences Inc | 9.25% | -152.42% |
| PBH | Prestige Consumer Healthcare Inc | 8.18% | -146.35% |
| BCRX | Biocryst Pharmaceuticals Inc | 6.24% | -135.36% |
| BHC | Bausch Health Companies Inc | 2.51% | -114.23% |
| RDY | Dr. Reddy`s Laboratories Ltd | 2.45% | -113.87% |
| YCBD | cbdMD Inc | 1.50% | -108.50% |